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SUMMARY – New estimates show reduction in the number of people who are blind or suff er 
from vision impairment as a sequel of infectious diseases, while there is an increase in the number 
of people who are blind due to conditions related to longer life span and diabetes. Diabetic retino-
pathy is the leading cause of blindness in active population in developed countries. Epidemiological 
studies evaluated the incidence and describe many facets of this disease the incidence of which is 
being followed in most countries. Th e aim of this paper is to present some epidemiological data on 
diabetic retinopathy caused by type 1 diabetes in Croatia, to compare them with other countries, 
and to evaluate its importance in causing severe visual impairments and blindness. Th ese data are 
considered highly relevant because they are changing constantly and require continuous monitoring 
in spite of all advances in understanding the distribution, causes and severity of diabetic retinopathy. 
It is of great importance because the increasing burden of diabetes will pose ever greater burden on 
the population at large and on healthcare systems providing care for these patents.
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Introduction
Although the number of people who are blind 
due to infectious diseases is on a decline according to 
World Health Organization reports, there is a growing 
problem of the increasing number of people aff ected 
with blindness in association with longevity. Th ere are 
more than 37 million blind people and over 161 mil-
lion people with impaired vision in the world1. Most 
of these blind people (90%) live in developing and un-
derdeveloped countries. It should be noted that blind-
ness could have been avoided in 75% of these cases1. 
However, it is also true that the number comes down 
to 50% in children1. As shown in Figure 1, cataract is 
the most common cause of blindness, accounting for 
47.8% of cases, while diabetic retinopathy with 5% is 
the fi fth leading cause of blindness worldwide1.
Diabetes and its complications are a major cause 
of morbidity and mortality in industrialized countries 
and contribute substantially to healthcare costs. Al-
though the prevalence of diabetes is high in the world, 
Fig. 1. Causes of blindness in the world.
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its incidence can be expected to rise continually with 
aging of the population and growing rate of obesity in 
both adults and children. In addition, diabetes in chil-
dren and young adults has become an increasingly se-
rious health problem, which will result in more people 
having and managing diabetes for most of their lives.
Although most of diabetes burden in the world is due 
to type 2 diabetes, due understanding of the diff erent 
types of diabetes and their health impact is warranted.
Th is article reviews the literature on the epidemi-
ology of diabetes and compares some epidemiologi-
cal data from the Split-Dalmatia County (Croatia) 
with available data from the rest of the world (Africa, 
North America, South-Central America, Europe, 
Middle East and Th ailand).
Th e Pathophysiology of Diabetes
Diabetes mellitus is a group of chronic metabolic 
conditions, all of which are characterized by elevated 
blood glucose levels resulting from the body’s inability 
to produce insulin, or resistance to insulin action, or 
both2. Th is group of conditions can be subdivided into 
4 clinically distinct types; 1) type 1 diabetes, which 
results from autoimmune beta cell destruction in the 
pancreas; 2) type 2 diabetes, which develops when 
there is an abnormally increased resistance to the ac-
tion of insulin and the body cannot produce enough 
insulin to overcome the resistance; 3) gestational dia-
betes, which is a form of glucose intolerance that af-
fects some women during pregnancy; and 4) a group 
of other types of diabetes caused by specifi c genetic 
defects of beta cell function or insulin action, diseases 
of the pancreas, or drugs or chemicals2.
Type 1 diabetes accounts for 5% to 10% of all 
cases of diabetes. Its risk factors include autoimmune, 
genetic, and environmental factors. Type 2 diabetes 
accounts for 90% to 95% of all diagnosed diabetes 
cases3.
Th e Incidence and Prevalence of Diabetic
Retinopathy
Th e incidence (or new cases) of diabetes describes 
increases in the number of people aff ected by the 
disease, while the prevalence (or existing cases) of 
diabetes describes the overall burden of the disease 
in the population. Population based sources state that 
the actual mean prevalence of diabetes in Europe is 
around 2%, with the highest prevalence reported in 
Malta (7.7%)4. Data on Croatia indicate the preva-
lence of diabetes to be 6.1%, with a signifi cant age 
diff erence and the undiagnosed to diagnosed diabetes 
ratio of 72:1005. Th e incidence of blindness in Europe 
has been estimated to 50-65 per 100,000 diabetic in-
dividuals per year6-9.
Diabetes is associated with many complications. 
Eye complications are among the most common ones 
and usually develop earlier than other complications 
(Fig. 2)10. Diabetic retinopathy is by far the most com-
mon eye complication; it is the cause of blindness in 
2.9% of diabetic patients in Croatia11.
Type 1 diabetes is also a growing problem be-
cause 5%-10% of all diabetic patients suff er from it. 
Th e prevalence of type 1 diabetes in Europe is among 
highest in the world (Fig. 3)12. Some countries, like 
Finland, struggle with extremely high incidences of 
type 1 diabetes (43.9/100,000 children aged 0-14)13. 
Finland is followed by Canada with an incidence of 
Fig. 2. Prevalence of diabetic complications.
Fig. 3. Prevalence of type 1 diabetes according to world 
regions.
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23/100,000 children, Australia with 19.3 /100,000 
children, and USA with 17/100,000 children per 
year13. On the other hand, other countries like United 
Kingdom, Hungary, Hawaii, and China are faced 
with a high relative increase in the incidence of type 
1 diabetes14.
One of our previous studies can give an orientation 
in the situation with type 1 diabetes in Croatia. In 
that study, we assessed the incidence of diabetic retin-
opathy as the most common diabetic complication 
in children and young adults in the Split-Dalmatia 
County. Diabetic retinopathy was recorded in 66.7% 
of study patients. Th e mean time elapsed from the di-
agnosis of type 1 diabetes to enrolment in the study 
was 16.6 years for patients with diabetic retinopathy 
and 6.5 years for patients without diabetic retinopathy. 
Nonproliferative retinopathy was present in 56.7% 
and proliferative retinopathy in 10% of these 66.7% 
of patients with diabetic retinopathy. In patients with 
proliferative diabetic retinopathy, the mean time from 
the diagnosis of type 1 diabetes was 22.1 years15.
Th e prevalence of diabetic retinopathy in patients 
with type 1 diabetes varies from author to author. 
Figure 4 shows the prevalence of diabetic retinopathy 
reported only from studies that included patients hav-
ing suff ered from type 1 diabetes for 4-9 years16-21. Th e 
data recorded in our previous study conducted in the 
Split-Dalmatia County are consistent with the mean 
values presented in Figure 421. Figure 5 illustrates the 
prevalence of diabetic retinopathy in patients treated 
for type 1 diabetes for 13-17 years15,22-24. A similar re-
lation to data reported by other authors is also seen for 
proliferative diabetic retinopathy, where we collected 
data for the Split-Dalmatia County on patients diag-
nosed with type 1 diabetes for less than 30 years (Fig. 
6)16-18,21,25.
Discussion
Diabetic retinopathy is the most common cause 
of vision loss in active population in industrial-
ized countries. Th erefore, better screening for sight 
threatening diabetic retinopathy should be system-
atic and regular. Th e increasing incidence of type 
1 diabetes is an upcoming problem because if left 
untreated or poorly treated, it leads to serious vision 
loss in young active people. It is known that retinop-
athy is rare during the fi rst 5 years of type 1 diabetes. 
Early recognition will identify patients at a high risk, 
who will benefi t most from therapy. It is also impor-
tant to sensitize these patients about the importance 
of good blood glucose control and annual dilated 
eye examinations and possibly retinal photography, 
which should be the standard of care implemented 
from the onset of type 1 diabetes and not delayed 
Fig. 4. Prevalence of diabetic retinopathy in children suf-
fering from type 1 diabetes for 4-9 years. 
Fig. 5. Prevalence of diabetic retinopathy in children suf-
fering from type 1 diabetes for 13-17 years.
Fig. 6. Prevalence of proliferative diabetic retinopathy in 
patients suff ering from type 1 diabetes for 10-29 or >30 
years.
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for 3-5 years. Th ese goals could be achieved through 
education, better therapeutics and evolving health-
care support systems. 
Although diabetic retinopathy remains the leading 
cause of preventable blindness in working adults, there 
are primary and secondary interventions proven eff ec-
tive in limiting visual loss. Th e indications, effi  cacy, 
and safety of newer medical and surgical treatments, 
however, also require further evaluation.
It is also important to stress that systematic epide-
miological studies are needed to warrant good organi-
zation of the healthcare system, which would be able 
to off er support to these patients.
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Sažetak
SLJEPOĆA I POREMEĆAJI VIDA KOD DIJABETIČARA U HRVATSKOJ
K. Bućan, Lj. Znaor, M. Ivanišević, D. Galetović, L. Bojić i D. Bućan
Najnovije procjene ukazuju na smanjenje broja slijepih osoba i osoba sa slabijim vidom uzrokovanih zaraznim bole-
stima, no sve je veći broj ljudi slijepih zbog bolesti vezanih za produženje životnog vijeka ljudi i dijabetes. Dijabetična 
retinopatija je vodeći uzrok sljepoće u radnoj populaciji u razvijenim zemljama. Mnoge epidemiološke studije su procijenile 
incidenciju i sagledale ovu bolest iz svih njezinih aspekata. Cilj ovoga rada je prikazati epidemiološke podatke o dijabetič-
noj retinopatiji uzrokovanoj dijabetesom tip 1 u Hrvatskoj, te ih usporediti s podatcima iz drugih zemalja i ocijeniti koliko 
ona utječe na broj slijepih osoba i osoba sa slabijim vidom. Smatramo ove podatke bitnima unatoč napretku u saznanjima 
o mehanizmima, raspodjeli i uzrocima bolesti. Treba također naglasiti da se ovi podatci neprestance mijenjaju i zbog toga 
ih valja stalno pratiti. To je osobito važno zbog toga što dijabetes uzrokuje veliko opterećenje za zajednicu i zdravstveni 
sustav koji se skrbi o ovim bolesnicima.
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